The largest database of trusted experimental protocols

Adcc assay buffer

Manufactured by Promega

The ADCC assay buffer is a reagent used in the performance of antibody-dependent cell-mediated cytotoxicity (ADCC) assays. The buffer provides the necessary components to facilitate the interaction between effector cells and target cells, which is a key step in the ADCC process. The specific composition and formulation of the buffer are designed to support the assay conditions required for the evaluation of ADCC activity.

Automatically generated - may contain errors

5 protocols using adcc assay buffer

1

Antibody-Dependent Cell-Mediated Cytotoxicity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
U-bottom microplates (untreated) were coated overnight with antibody and fragments, fibronectin or BSA with 100 mL of 10 μg/mL protein in 0.2 M bicarbonate buffer, pH 9.4 at 4°C. Wells were washed and blocked with 200 mL PBS/1% BSA for 1 hr at room temperature. 2.5×104 Jurkat or CHO cell transfectants expressing CD16a, 32a or 64a were added with or without sCA125 to wells in a total volume of 100 μL ADCC assay buffer (Promega). Microplates were placed at 37°C/5% CO2 for 5 hr then imaged using an EVOS imaging system (Thermo-Fisher, Waltham, MA). Cell cluster diameter was quantitated by A405 using a SpectraMax M5 (Molecular Devices, Downingtown, PA). sCA125 competition studies were done using 50 μg/mL of antibody or antibody fragment. sCA125-mesothelin absorption is described in Supplementary Methods.
+ Open protocol
+ Expand
2

ADCC Reporter Bioassay for Antibody Screening

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 9

ADCC Reporter Bioassay

2.5×104 HCC1428 cells in 100 μL culture medium/well were incubated in 96-well cell culture plate (Greiner, Cat #655083-1) at 37° C. in a humidified 5% CO2 incubator (NUAIRE, Cat #NU-4750) overnight. Culture medium was replaced with 2× serial dilution of 37.5 μL OBI-898 from 20 to 0.000305 μm/mL in ADCC Assay Buffer (Promega, Cat #G708A, G711A). In addition, background wells which contained no antibody were included. In each well, 37.5 μL of 7.5×104 ADCC Bioassay Effector cells (Promega, Cat #G701A) were added. Induction was performed for six hours and 75 μL of Bio-Glo Luciferase Assay Reagent (Promega, Cat #G719A, G720A) was added. After 15 minutes, luminescence (RLU, relative light unit) was determined using a microplate luminometer, SpectraMax L (Molecular Devices, Sunnyvale, Calif.).

Luminescence induction of fold changes was calculated by the ratio of relative light unit (RLU) (induced) to RLU (no antibody control). EC50 was determined by plotting x (concentration in μg/mL)−y (the induction of fold change) and fitting the data in a 4PL nonlinear regression model by PRISM 6 Software.

According to FIG. 15, The EC50 response of c1J1s, H4-16K2, H4-16K2 N56Q, H4-16K2 N56S, H4-16K2 N58Y and H4-16K2 K3T/N56Q were 987.2, 50.7, 9.7, 9.2, 21.2 and 8.3 μg/mL, respectively. It showed that H4-16K2 K3T/N56Q clone has best ADCC activity.

+ Open protocol
+ Expand
3

ADCC Bioassay for Antibody Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monoclonal antibodies were serially diluted in ADCC assay buffer (Promega). Target cells (A549-H1 HA, A/California/04/2009) were added in a white flat-bottom 96-well plate at 1.25 × 104 cells per well in 25 μl, then serially diluted antibodies were added to each well (25 μl per well), and the antibody and cell mixture was incubated for 10 min at room temperature. Effector cells (Jurkat-FcγRIIIa) for the ADCC Bioassay are thawed and added at a cell density of 7.5 × 104 per well in 25 μl (effector to target ratio of 6:1). Plates were incubated for 20 h at 37 °C with 5% CO2. Activation of human FcγRIIIa (V158 or F158 variants) in this bioassay results in the NFAT-mediated expression of the luciferase reporter gene. Luminescence is therefore measured with a luminometer (Synergy H1, Biotek) using the BioGlo Luciferase Assay Reagent according to the manufacturer’s instructions. The data (that is, specific FcγRIIIa activation) are expressed as the average of relative luminescence units (RLU) over the background by applying the following formula: (RLU at concentration x of monoclonal antibodies − RLU of background).
+ Open protocol
+ Expand
4

ADCC Reporter Bioassay for Antibody Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 9

ADCC Reporter Bioassay

2.5×104 HCC1428 cells in 100 μL culture medium/well were incubated in 96-well cell culture plate (Greiner, Cat #655083-1) at 37° C. in a humidified 5% CO2 incubator (NUAIRE, Cat #NU-4750) overnight. Culture medium was replaced with 2× serial dilution of 37.5 μL OBI-898 from 20 to 0.000305 μg/mL in ADCC Assay Buffer (Promega, Cat #G708A, G711A). In addition, background wells which contained no antibody were included. In each well, 37.5 μL of 7.5×104 ADCC Bioassay Effector cells (Promega, Cat #G701A) were added. Induction was performed for six hours and 75 μL of Bio-Glo Luciferase Assay Reagent (Promega, Cat #G719A, G720A) was added. After 15 minutes, luminescence (RLU, relative light unit) was determined using a microplate luminometer, SpectraMax L (Molecular Devices, Sunnyvale, Calif.).

Luminescence induction of fold changes was calculated by the ratio of relative light unit (RLU) (induced) to RLU (no antibody control). EC50 was determined by plotting x (concentration in μg/mL)−y (the induction of fold change) and fitting the data in a 4PL nonlinear regression model by PRISM 6 Software.

According to FIG. 15, The EC50 response of c1J1s, H4-16K2, H4-16K2 N56Q, H4-16K2 N56S, H4-16K2 N58Y and H4-16K2 K3T/N56Q were 987.2, 50.7, 9.7, 9.2, 21.2 and 8.3 μg/mL, respectively. It showed that H4-16K2 K3T/N56Q clone has best ADCC activity.

+ Open protocol
+ Expand
5

FcγRIIIa-Mediated ADCC Bioassay

Check if the same lab product or an alternative is used in the 5 most similar protocols
MAbs were serially diluted in ADCC Assay buffer (Promega). Target cells (A549-H1 HA, A/California/04/2009) were added in a white flat bottom 96-well plate at 1.25×104 cells/well in 25 μl, then serially diluted antibodies were added to each well (25 μl per well), and the antibody/cell mixture was incubated for 10 min at room temperature. Effector cells (Jurkat-FcγRIIIa) for the ADCC Bioassay are thawed and added at a cell density of 7.5×104/well in 25 μl (effector to target ratio of 6:1). Plates were incubated for 20 hours at 37°C with 5% CO2. Activation of human FcγRIIIa (V158 or F158 variants) in this bioassay results in the NFAT-mediated expression of the luciferase reporter gene. Luminescence is therefore measured with a luminometer (Synergy H1, Biotek) using the BioGlo™ Luciferase Assay Reagent according to the manufacturer’s instructions. The data (i.e. specific FcγRIIIa activation) are expressed as the average of relative luminescence units (RLU) over the background by applying the following formula: (RLU at concentration x of mAbs – RLU of background).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!